Biochemical serum markers in head injury: An emphasis on clinical utility

Clinical Neurosurgery

Volumn 57, Issue , 2010, Pages 134-140

  Mehta, Samit Satish ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEURON SPECIFIC ENOLASE; PROTEIN S100B; BIOLOGICAL MARKER; ENOLASE; PROTEIN S 100;

ADOLESCENT; ADULT; ASTROCYTE; BLOOD ANALYSIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; EARLY INTERVENTION; FEMALE; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; TRAUMATIC BRAIN INJURY; ARTICLE; BLOOD; COMPUTER ASSISTED TOMOGRAPHY; GLASGOW OUTCOME SCALE; HEAD INJURY; PREDICTIVE VALUE; REPRODUCIBILITY; SOLUBILITY;

ADULT; BIOLOGICAL MARKERS; CRANIOCEREBRAL TRAUMA; GLASGOW OUTCOME SCALE; HUMANS; MALE; PHOSPHOPYRUVATE HYDRATASE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; S100 PROTEINS; SOLUBILITY; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 79952650673     PISSN: 00694827     EISSN: 0148396X     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (41)

1. Bakay RA, Ward AA. Enzymatic changes in serum and cerebrospinal fluid in neurological injury. J Neurosurg. 1983;58(1):27-37. (Pubitemid 13220944)
2. Berger RP, Adelson PD, Pierce MC, Dulani T, Cassidy LD, Kochanek PM. Serum neuron-specific enolase, S-100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children. J Neurosurg. 2005;103(1)(Suppl):61-68. (Pubitemid 44954950)
3. Ingebrigtsen T, Romner B. Biochemical serum markers of traumatic brain injury. J Trauma. 2002;52(4):798-808. (Pubitemid 34437255)
4. Nylen KJ, Ost M, Csajbok LZ, Nilsson I, Blennow K, Nellgard B, Rosengren L. Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome. Neurol Sci. 2006;240(1-2):85-91. (Pubitemid 41814959)
5. Teasdale G, Jennett B. Assessment of coma and impaired consciousness: a practical scale. Lancet. 1974;2(7872):81-84.
6. Moore BW, McGregor D. Chromatographic and electrophoretic fractionation of soluble proteins of brain and liver. J Biol Chem. 1965; 240:1647-1653.
7. Astudillo R, Van der Linden J, Radegran K, Hansson LO, Aberg B. Elevated serum levels of S-100 after deep hypothermic arrest correlate with duration of circulatory arrest. Eur J Cardiothorac Surg. 1996;10(12): 1107-1113. (Pubitemid 126690857)
8. Korfias S, Stranjalis G, Boviatsis E, et al. Serum S-100B protein monitoring in patients with severe traumatic brain injury. Intensive Care Med. 2007;33(2):255-260. (Pubitemid 46221230)
9. Donato R. Functional roles of S-100 proteins, calcium-binding proteins of the EF-hand type. Biochim Biophys Acta. 1999;1450(3):191-231. (Pubitemid 29295473)
10. Missler U, Wiesmann M, Wittmann G, Magerkurth O, Hagenstrom H. Measurement of glial fibrillary acidic protein in human blood: analytical method and preliminary clinical results. Clin Chem. 1999;45(1):138-141. (Pubitemid 29036401)
11. Jönsson H, Johnsson P, Höglund P, Alling C, Blomquist S. The elimination of S-100b and renal function after cardiac surgery. J Cardiothorac Vasc Anesth. 2000;14(6):698-701.
12. Langbakk B, Romner B. Age and sex-related changes of S-100 protein concentrations in cerebrospinal fluid and serum in patients with no previous history of neurological disorders. Clin Chem. 1997;43:541-543. (Pubitemid 27106494)
13. Nygaard, Langbakk B, Romner B. Age- and sex-related changes of S-100 protein concentrations in cerebrospinal fluid and serum in patients with no previous history of neurological disorder. Clin Chem. 1997;43(3): 541-543. (Pubitemid 27106494)
14. Wiesmann M, Missler U, Gottman D, Gehring S. Plasma S-100b protein concentration in healthy adults is age and sex independent. Clin Chem. 1998;44(5):1056-1058. (Pubitemid 28213152)
15. Moore BW. A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun. 1965;19(6):739-744.
16. Cooper EH. Neuron-specific enolase. Int J Biol Markers. 1994;4:205-210. (Pubitemid 24350340)
17. Johnsson P. Markers of cerebral ischemia after cardiac surgery. J Cardiothorac Vasc Anesth. 1996;10(1):120-126. (Pubitemid 26048448)
18. Bakay RA, Sweeney KM, Wood JH. Pathophysiology of cerebrospinal fluid in head injury, part 2: biochemical markers for central nervous system trauma. Neurosurgery. 1986;18(3):376-382. (Pubitemid 16139401)
19. Herrmann M, Jost S, Kutz S, et al. Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography. J Neurotrauma. 2000;17(2):113-122. (Pubitemid 30120300)
20. Raabe A, Menon DK, Gupta S, Czosnyka M, Pickard JD. Jugular venous and arterial concentrations of serum S-100B protein in patients with severe head injury: a pilot study. J Neurol Neurosurg Psychiatry. 1998; 65(6):930-932. (Pubitemid 128710439)
21. Ergun R, Bostanci U, Akdemir G, et al. Prognostic value of serum neuron-specific enolase levels after head injury. Neurol Res. 1998; 20(5):418-420. (Pubitemid 28304575)
22. Skogseid IM, Nordby HK, Urdal P, Paus E, Lilleaas F. Increased serum creatine kinase BB and neuron specific enolase following head injury indicates brain damage. Acta Neurochir (Wien). 1992;115(3-4):106-111.
23. Dauberschmidt R, Zinsmeyer J, Mrochen H, et al. Changes of neuron-specific enolase concentration in plasma after cardiac arrest and resuscitation. Mol Chem Neuropathol. 1991;14(3):237-245.
24. Fogel W, Krieger D, Veith M, et al. Serum neuron-specific enolase as early predictor of outcome after cardiac arrest. Crit Care Med. 1997; 25(7):1133-1138. (Pubitemid 27310251)
25. Karkela J, Bock E, Kaukinen S. CSF and serum brain specific creatine kinase isoenzyme (CK-BB), neuron-specific enolase (NSE) and neural cell adhesion molecule (NCAM) as prognostic markers for hypoxic brain injury after cardiac arrest in man. J Neurol Sci. 1993;116(1):100-109. (Pubitemid 23144800)
26. Pelinka LE, Hertz H, Mauritz W, Harada N, Jafarmadar M, Albrecht M, Redl H, Bahrami S. Nonspecific increase of systemic neuron-specific enolase after trauma: clinical and experimental findings. Shock. 2005; 24(2):119-123. (Pubitemid 41105508)
27. Pelinka LE, Jafarmadar M, Redl H, Bahrami S. Neuron-specific-enolase is increased in plasma after hemorrhagic shock and after bilateral femur fracture without traumatic brain injury in the rat. Shock. 2004;22(1): 88-91. (Pubitemid 40228216)
28. Ross SA, Cunningham RT, Johnston CF, Rowlands BJ. Neuronspecific enolase as an aid to outcome prediction in head injury. Br J Neurosurg. 1996;10(5):471-476. (Pubitemid 26361431)
29. Schaarschmidt H, Prange HW, Reiber H. Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases. Stroke. 1994;25(3):558-565. (Pubitemid 24067066)
30. Schoerkhuber W, Kittler H, Sterz F, et al. Time course of serum neuron-specific enolase: a predictor of neurological outcome in patients resuscitated from cardiac arrest. Stroke. 1999;30(8):1598-1603. (Pubitemid 29379609)
31. Stelzl T, Von Bose MJ, Hogl B, et al. A comparison of the prognostic value of neuron-specific enolase serum levels and somatosensory evoked potentials in 13 reanimated patients. Eur J Emerg Med. 1995;2(1):24-27.
32. Tiainen M, Roine RO, Pettila V, et al. Serum neuron-specific enolase and S-100B protein in cardiac arrest patients treated with hypothermia. Stroke. 2003;34(12):2881-2886. (Pubitemid 37517761)
33. Vos PE, Lamers KJ, Hendriks JC, et al. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology. 2004;62(8):1303-1310. (Pubitemid 38526041)
34. Hardemark HG, Almqvist O, Johansson T, Pahlman S, Persson L. S-100 protein in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: relation to functional outcome, late CT and SPECT changes, and signs of higher cortical dysfunction. Acta Neurochir (Wien). 1989;99 (3-4):135-144. (Pubitemid 19196383)
35. Woertgen C, Rothoerl RD, Holzschuh M, Metz C, Brawanski A. Comparison of serial S-100 and NSE serum measurements after severe head injury. Acta Neurochir (Wien). 1997;139(12):1161-1165. (Pubitemid 28014897)
36. Dauberschmidt R, Marangos PJ, Zinsmeyer J, Bender V, Klages G, Gross J. Severe head trauma and the changes of concentration of neuron-specific enolase in plasma and in cerebrospinal fluid. Clin Chim Acta. 1983;131(3):165-170. (Pubitemid 13059034)
37. Li N, Shen JK, Zhao WG, Cai Y, Li YF, Zhan SK. S-100B and neuron specific enolase in outcome prediction of severe head injury. Chin J Traumatol. 2004;7(3):156-158. (Pubitemid 38786904)
38. McKeating EG, Andrews PJD, Mascia L. Relationship of neuron specific enolase and protein S-100 concentrations in systematic and jugular venous serum to injury severity and outcome after traumatic brain injury. Acta Neurochir Suppl (Wien). 1998;71:117-119. (Pubitemid 128444374)
39. Raabe A, Grolms C, Seifert V. Serum markers of brain damage and outcome prediction in patients after severe head injury. Br J Neurosurg. 1999;13(1):56-59. (Pubitemid 29139950)
40. Woertgen C, Rothoerl RD, Metz C, Brawanski A. Comparison of clinical, radiologic, and serum marker as prognostic factors after severe head injury. J Trauma. 1999;47(6):1126-1130. (Pubitemid 30007572)
41. Raabe A, Grolms C, Keller M, Döhnert J, Sorge O, Seifert V. Correlation of computed tomography findings and serum brain damage markers following severe head injury. Acta Neurochir (Wien). 1998;140(8): 787-792. (Pubitemid 28419961)